[Effect of cardiac glycosides on myocardial metabolism during cardiac insufficieny].
D000818:Animals; D001001:Anura; D050260:Carbohydrate Metabolism; D002301:Cardiac Glycosides / Q000494:pharmacology* / Q000627:therapeutic use / Q000633:toxicity; D003327:Coronary Disease / Q000378:metabolism; D004285:Dogs; D006019:Glycolysis / Q000187:drug effects; D006321:Heart / Q000187:drug effects; D006327:Heart Block / Q000150:complications; D006331:Heart Diseases / Q000188:drug therapy / Q000378:metabolism*; D006801:Humans; D006947:Hyperkalemia / Q000139:chemically induced; D006955:Hypernatremia / Q000139:chemically induced; D007008:Hypokalemia / Q000139:chemically induced; D008944:Mitral Valve Insufficiency / Q000378:metabolism; D009119:Muscle Contraction / Q000187:drug effects; D009206:Myocardium / Q000378:metabolism*; D010710:Phosphates / Q000096:biosynthesis; D011188:Potassium / Q000032:analysis; D012964:Sodium / Q000032:analysis; D014693:Ventricular Fibrillation / Q000150:complications
D002301:Cardiac Glycosides; D010710:Phosphates; D012964:Sodium; D011188:Potassium
Vliianie serdechnykh glikozidov na obmen veshchestv miokarda pri serdechnoĭ nedostatochnosti.